biolongevity labs retatrutide GLP-3(10185) Peptides - hit or miss?

GLP-1 receptor agonists and Breast Cancer risk

2021 Jul 12;10:e49

Amble acts as a managed services provider and does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy

For those who might consider alternatives, we will discuss other medications and treatments

One particularly noteworthy association that stood out is the significant risk reduction across multiple gastrointestinal cancers, including colorectal, esophageal, stomach, gallbladder, liver and pancreatic cancers, Wang said

Scar tissue and lipohypertrophy (fat accumulation) make injection more difficult and more noticeable